Synthesis and quantitative structure-activity relationship of hydrazones of N-Amino-N′-hydroxyguanidine as electron acceptors for xanthine oxidase

被引:22
作者
Prusis, P
Dambrova, M
Andrianov, V
Rozhkov, E
Semenikhina, V
Piskunova, I
Ongwae, E
Lundstedt, T
Kalvinsh, I
Wikberg, JES [1 ]
机构
[1] Uppsala Univ, Dept Pharmaceut Biosci, Div Pharmacol, SE-75124 Uppsala, Sweden
[2] Latvian Inst Organ Synth, Dept Med Chem, Riga, Latvia
[3] Uppsala Univ, Dept Pharmaceut Chem, SE-75124 Uppsala, Sweden
[4] Uppsala Univ, Melacure Therapeut AB, SE-75124 Uppsala, Sweden
关键词
D O I
10.1021/jm031127c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new N-hydroxyguanidines were synthesized and tested for electron acceptor activity on bovine milk xanthine oxidase using xanthine as reducing substrate. Manual inspection of the structure-activity data revealed that molecules containing nitro groups ("set A") show a different structure-activity relationship pattern compared to non-nitro compounds ("set B"). Accordingly separate QSAR models were built and validated for the two sets. Substantial differences were found in properties governing acceptor activity for the models, the only common property being sterical access to the imino nitrogen atom of the hydroxyguanidinimines. For set A molecules the presence of a nitro substituent at a certain distance range from the hydroxuguanidino group was most important. In addition, the presence of a nitro group in the ortho position interacting with NH2 of the hydroxyguanidino group, and the mutual geometry of the phenyl ring, hydroxyguanidine, and imine groups was important for this set. By contrast, for set B molecules the acceptor activity was most influenced by the geometry of methoxy groups and the size and geometry of meta and para substituents of the phenyl ring.
引用
收藏
页码:3105 / 3110
页数:6
相关论文
共 46 条
[1]  
ALLEN FH, 1993, CHEM DESIGN AUTOMATI, V8, P1
[2]  
Ar'Rajab A, 1996, New Horiz, V4, P224
[3]   GENERATING OPTIMAL LINEAR PLS ESTIMATIONS (GOLPE) - AN ADVANCED CHEMOMETRIC TOOL FOR HANDLING 3D-QSAR PROBLEMS [J].
BARONI, M ;
COSTANTINO, G ;
CRUCIANI, G ;
RIGANELLI, D ;
VALIGI, R ;
CLEMENTI, S .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1993, 12 (01) :9-20
[4]   THE KINETICS OF 1-NITROPYRENE AND 3-NITROFLUORANTHENE METABOLISM USING BOVINE LIVER XANTHINE-OXIDASE [J].
BAUER, SL ;
HOWARD, PC .
CANCER LETTERS, 1990, 54 (1-2) :37-42
[5]  
BRAY RC, 1976, ENZYMES, P299
[6]   IMPROVEMENT OF CARDIAC-FUNCTION BY ALLOPURINOL IN PATIENTS UNDERGOING CARDIAC-SURGERY [J].
CASTELLI, P ;
CONDEMI, AM ;
BRAMBILLASCA, C ;
FUNDARO, P ;
BOTTA, M ;
LEMMA, M ;
VANELLI, P ;
SANTOLI, C ;
GATTI, S ;
RIVA, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (01) :119-125
[7]   Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest [J].
Clancy, RR ;
McGaurn, SA ;
Goin, JE ;
Hirtz, DG ;
Norwood, WI ;
Gaynor, JW ;
Jacobs, ML ;
Wernovsky, G ;
Mahle, WT ;
Murphy, JD ;
Nicolson, SC ;
Steven, JM ;
Spray, TL .
PEDIATRICS, 2001, 108 (01) :61-70
[8]   NITROIMIDAZOLES AS ANAEROBIC ELECTRON-ACCEPTORS FOR XANTHINE-OXIDASE [J].
CLARKE, ED ;
GOULDING, KH ;
WARDMAN, P .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (20) :3237-3242
[9]   Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at α2-adrenoceptors II.: Description of a xanthine-dependent enzymatic activity in spleen cytosol [J].
Dambrova, M ;
Uhlén, S ;
Welch, CJ ;
Prusis, P ;
Wikberg, JES .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (09) :1121-1128
[10]   The novel guanidine ME10092 protects the heart during ischemia-reperfusion [J].
Dambrova, M ;
Veveris, M ;
Cirule, H ;
Pugovichs, O ;
Post, C ;
Lundstedt, T ;
Kalvinsh, L ;
Skottner, A ;
Wikberg, JES .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 445 (1-2) :105-113